OptimizeRx Corp. OPRX 深 沪
等待开盘 09-18 09:30:00 美东时间
17.78
-0.340
-1.88%
华盛通- 最 高18.43
- 今 开18.04
- 成交量 16.44万股
- 最 低 17.73
- 昨 收 18.12
- 总市值 3.30亿
- 52周最高 19.25
- 市盈率 静 --
- 换手率 0.89%
- 52周最低 3.78
- 委 比 92.64%
- 总股本 1856.50万
- 历史最高 99.178
- 量 比 0.39
- 振 幅 3.86%
- 历史最低 3.78
- 每 手 1
- 风险率 4.19%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多OptimizeRx to Participate in the 9th Annual Lake Street Capital Best Ideas Growth Conference
OptimizeRx Corp. will participate in the 9th Annual Lake Street Capital Best Ideas Growth Conference on September 11, 2025, in New York, NY. The company, a leading healthcare technology provider, connects life science brands with patients and healthcare professionals through innovative AI-driven tools, ensuring privacy-safe and patient-centric solutions.
09-10 11:30
OptimizeRx Partners With Lamar Advertising To Revolutionize OOH Advertising For Pharmaceutical And Healthcare Brands
Strategic Partnership Combines OptimizeRx's Patented Micro-Neighborhood® Targeting Data with Lamar's Vast Nationwide OOH Network to Strengthen OOH Media for Healthcare MarketingWALTHAM, Mass., Sept. 09, 2025
09-10 04:14
OptimizeRx Partners with Lamar Advertising to Reach Clinically Relevant Audiences Through Out-of-Home Healthcare Advertising
OptimizeRx and Lamar Advertising Company have formed a strategic partnership to enhance out-of-home (OOH) advertising for healthcare brands. By integrating OptimizeRx's patented Micro-Neighborhood Targeting (MNT) data with Lamar's全国户外广告网络，双方为制药企业提供精准的临床相关户外广告解决方案，同时保持成本效益和可衡量的结果。
09-09 20:05
OptimizeRx Appoints Brendan Merrell As COO
OptimizeRx Corp. (the "Company") (NASDAQ:OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced
08-19 19:39
OptimizeRx Corporation Announces Leadership Team Advancements to Accelerate Strategic Growth
WALTHAM, Mass., Aug. 19, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading healthcare technology company, announced organizational updates and leadership advancements to accelerate its Rule of 40 strategy, balancing growth and profitability. CEO Steve Silvestro highlighted the Company’s confidence in its talent and commitment to strategic clarity. Key leadership changes include Ed Stelmakh as Chief Financial & Strategic Officer,...
08-19 11:30
Stifel Maintains Buy on OptimizeRx, Raises Price Target to $18
Stifel analyst David Grossman maintains OptimizeRx (NASDAQ:OPRX) with a Buy and raises the price target from $16 to $18.
08-08 22:30
OptimizeRx shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY25 sales guidance above estimates.
OptimizeRx shares are trading higher after the company reported better-than-exp...
08-08 04:58
Earnings Scheduled For August 7, 2025
Companies Reporting Before The Bell • GoHealth (NASDAQ:GOCO) is estimated to re...
08-07 16:33
OptimizeRx Sets Second Quarter 2025 Conference Call for August 7, 2025, at 4:30 p.m. ET
OptimizeRx Corp. will host a conference call on August 7, 2025, at 4:30 p.m. Eastern Time, to discuss its second quarter 2025 financial results. The call will feature OptimizeRx management and include a Q&A session. Details to join the call or webcast are provided, along with instructions to dial in or log on five minutes prior to the start. A replay will be available for 12 months on the company's website. OptimizeRx is a healthcare technology c...
07-17 11:30
A Look Ahead: Simulations Plus's Earnings Forecast
Simulations Plus (NASDAQ:SLP) is gearing up to announce its quarterly earnings ...
07-11 22:01
